Samuel Sidi, PhD
- PROFESSOR | Cell, Developmental & Regenerative Biology
- PROFESSOR | Medicine, Hematology and Medical Oncology
- PROFESSOR | Oncological Sciences
Research Topics:
Cancer Genetics, Cell Biology, DNA Repair, Drug Design and Discovery, Drug Resistance, Genomics, Molecular Biology, Signal Transduction, Tumor Suppressor GenesMulti-Disciplinary Training Areas
Cancer Biology [CAB], Development Regeneration and Stem Cells [DRS], Genetics and Genomic Sciences [GGS]Education
BS/MS, Paris VII University
Instructor, Harvard Medical School
MS, Paris VI University
PhD, Max-Planck Institute for Developmental Biology, University of Tubingen, and Paris VI University
Postdoctoral fellowship, Dana-Farber Cancer Institute, Harvard Medical School
-
2016
Pershing Square Sohn Prize for Young Investigators in Cancer Research -
2012
Young Scientist Cancer Research Award -
2011
Searle Scholar -
2009
Claudia Adams Barr Award in Cancer Research -
2004
French Foundation for Medical Research (FRM) Scholarship -
2003
French Association for Cancer Research (ARC) Scholarship
Cancer target discovery in zebrafish (genetic and chemical-genetic approaches), mechanism of action of targeted therapies, development of molecular diagnostics. For more information, please visit the Sidi Laboratory.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr. Sidi did not report having any of the following types of financial relationships with industry during 2022 and/or 2023: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.